Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anna-Li Hanneforth"'
Autor:
Wen-Hsin Liu, Sophie M. Stief, Philipp A. Greif, Klaus H. Metzeler, Irmela Jeremias, Michael D. Bartoschek, Gunnar Schotta, Michela Carlet, Hilmar Quentmeier, Anna-Li Hanneforth, Heinrich Leonhardt, Maja Rothenberg-Thurley, Wolfgang Hiddemann, Sabrina Weser, Sebastian Vosberg, Karsten Spiekermann, Julia M. Kempf, Sebastian Bultmann, Helena Domínguez Moreno, Binje Vick, Raphael Mattes, Bianka Ksienzyk, Matthias Oettle, Belay Tizazu
Publikováno v:
Leukemia
Leukemia 34, 50-62 (2020)
Leukemia 34, 50-62 (2020)
Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm resulting from the malignant transformation of myeloid progenitors. Despite intensive chemotherapy leading to initial treatment responses, relapse caused by intrinsic or acquired drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af2bb72428e1b37d5f4bb399f480bb9
https://pubmed.ncbi.nlm.nih.gov/31201358
https://pubmed.ncbi.nlm.nih.gov/31201358
Autor:
Maja Rothenberg-Thurley, Wolfgang Hiddemann, Heinrich Leonhardt, Michael D. Bartoschek, Sabrina Weser, Sophie M. Stief, Wen-Hsin Liu, Karsten Spiekermann, Hilmar Quentmeier, Raphael Mattes, Sebastian Bultmann, Bianka Ksienzyk, Helena Domínguez Moreno, Binje Vick, Klaus H. Metzeler, Irmela Jeremias, Gunnar Schotta, Anna-Li Hanneforth
Publikováno v:
Blood. 132:3935-3935
Acute myeloid leukemia (AML) is an aggressive hematologic cancer resulting from the malignant transformation of myeloid progenitors. Despite intensive chemotherapy, relapse caused by intrinsic or acquired drug resistance remains a major hurdle in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd8975b20ffd5adf02b7871e2e7fb588
https://doi.org/10.1182/blood-2018-99-114959
https://doi.org/10.1182/blood-2018-99-114959